Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Nemani, Satish Kumar
Gudi, Satheesh Kumar
Guzmán, Carlos A
MetadataShow full item record
AbstractFollowing earlier studies on high-level intracellular production of hepatitis B surface antigen (HBsAg) using recombinant Pichia pastoris, we present here in detail an enhanced method for the purification of recombinant HBsAg virus-like particles (VLPs). We have screened various detergents for their ability to promote the solubilization of recombinant intracellular HBsAg. In addition, we have analyzed the effect of cell disruption and extraction regarding their impact on the release of HBsAg. Our results show that introduction of the mild nonionic detergent Tween 20 in the initial process of cell lysis at ∼600bars by high pressure homogenization leads to the best results. The subsequent purification steps involved polyethylene glycol precipitation of host cell contaminants, hydrophobic adsorption of HBsAg to colloidal silica followed by ion-exchange chromatography and either isopycnic density ultracentrifugation or size exclusion chromatography for the recovery of the VLPs. After final KSCN treatment and dialysis, a total yield of ∼3% with a purity of >99% was reached. The pure protein was characterized by electron microscopy, showing the presence of uniform VLPs which are the pre-requisite for immunogenicity. The intramuscular co-administration of HBsAg VLPs, with either alum or a PEGylated-derivative of the toll-like receptor 2/6 agonist MALP-2, to mice resulted in the elicitation of significantly higher HBsAg-specific IgG titers as well as a stronger cellular immune response compared to mice vaccinated with a gold standard vaccine (Engerix™). These results show that P. pastoris derived HBsAg VLPs exhibit a high potential as a superior biosimilar vaccine against hepatitis B.
CitationPurification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties. 2013, 940:104-11 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
AffiliationDepartment of Structural Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany; International Centre for Genetic Engineering and Biotechnology, New Delhi, India; Technology Research Centre, Department of Chemical, Biochemical and Environmental Engineering, University of Maryland Baltimore County, Baltimore, USA. Electronic address: email@example.com.
The following license files are associated with this item:
- Novel membrane extraction procedure for the purification of hepatitis B surface antigen from Pichia pastoris.
- Authors: Patil A, Khanna N
- Issue date: 2012 Jun 1
- Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris.
- Authors: Liu R, Lin Q, Sun Y, Lu X, Qiu Y, Li Y, Guo X
- Issue date: 2009 Aug
- Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing.
- Authors: Zahid M, Lünsdorf H, Rinas U
- Issue date: 2015 Jul 17
- Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen.
- Authors: Lünsdorf H, Gurramkonda C, Adnan A, Khanna N, Rinas U
- Issue date: 2011 Jun 26
- Improving stability of virus-like particles by ion-exchange chromatographic supports with large pore size: advantages of gigaporous media beyond enhanced binding capacity.
- Authors: Yu M, Li Y, Zhang S, Li X, Yang Y, Chen Y, Ma G, Su Z
- Issue date: 2014 Feb 28